Approvals/TGA/BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack

Approved

STANDARD

BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack

Lundbeck Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4edfd2456b15ed0d
Product Name: BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack
Artg Id: 203986
Artg Name: BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack
Sponsor: Lundbeck Australia Pty Ltd
Company Detail Path: /organization/lundbeck-australia-pty-ltd
Artg Date: 2014-03-31
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01012-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-01635-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

4edfd2456b15ed0d

Type

Standard